However, in human MND/ALS, patients with SOD1 mutations (MND‐SOD1) have a different pathological profile, lacking TDP‐43 proteinopathy and having less extramotor disease, and have a subtly different clinical profile compared to more common forms of disease. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.